{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-056505","form_type":"8-K","ticker":"SEM","cik":"0001320414","company_name":"SELECT MEDICAL HOLDINGS CORP","filed_at":"2022-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.200500+00:00","generated_at":"2026-06-25T23:25:48.683129+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Select Medical Q1 net income drops 59% to $55.9M; revenue up 3.4% to $1.60B","bullets":["Adjusted EBITDA fell 37% to $163.8M from $258.3M; operating income $104.0M vs $202.0M.","EPS $0.37 vs $0.82; critical illness hospital segment Adjusted EBITDA margin fell to 6.0% from 19.0%.","Dividend of $0.125 per share declared; payable June 1, 2022 to holders of record May 19, 2022.","Reaffirmed FY2022 revenue outlook $6.25B-$6.40B; labor climate cited for withholding EBITDA and EPS outlook.","Concentra segment Adjusted EBITDA up 9.1% to $89.5M with 21.1% margin; repurchased 2.1M shares in Q1."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-056505","json":"https://secwatch.observer/filing/0001104659-22-056505.json","markdown":"https://secwatch.observer/filing/0001104659-22-056505.md","text":"https://secwatch.observer/filing/0001104659-22-056505.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1320414/000110465922056505/0001104659-22-056505-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1320414/000110465922056505/tm2214579d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T23:25:48.683129+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}